Predicate |
Object |
contentType |
Comment|Journal Article |
endingPage |
840 |
issn |
1527-3350 0270-9139 |
issueIdentifier |
3 |
pageRange |
838-840 |
publicationName |
Hepatology (Baltimore, Md.) |
startingPage |
838 |
bibliographicCitation |
Kann M. Interfering with capsid formation: a practicable antiviral strategy against hepatitis B virus? Hepatology. 2004 Mar;39(3):838–40. doi: 10.1002/hep.20144. PMID: 14999705. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a78f1f9c4aea9d0f6bff35c2eca1cac |
date |
200403 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/14999705 https://doi.org/10.1002/hep.20144 |
isPartOf |
https://portal.issn.org/resource/ISSN/0270-9139 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4093 https://portal.issn.org/resource/ISSN/1527-3350 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Interfering with capsid formation: A practicable antiviral strategy against hepatitis B virus? |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8349 |